GXNPC-1

· Gwo Xi Stem Cell Applied Technology Co., Ltd.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for GXNPC-1, covering 2024-09-19 to 2024-09-19. Get the full timeline:

Most recent: Clinical Trial Update: An Open-labeled Phase II Study to Evaluate the Efficacy and Safety of GXNPC-1 in Patients with Chronic Stroke [Phase 2]

See pricing